Weiguang Biotechnology: Announcement of Resolutions of the Ninth Meeting of the Fourth Board of Directors
Securities code: 002880 Securities abbreviation: Weiguang Biology Announcement number: 2026-015
Shenzhen Weiguang Biological Products Co., Ltd.
Announcement of Resolutions of the Ninth Meeting of the Fourth Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Convening of board of directors meetings
The ninth meeting of the fourth board of directors of Shenzhen Weiguang Biological Products Co., Ltd. (hereinafter referred to as the company) was held on April 23, 2026 in the conference room on the fourth floor of the company's office building through on-site and communication methods. Nine directors were supposed to attend this meeting, but actually nine directors attended. The company's senior managers also attended the meeting. This meeting was presided over by Chairman Mr. Zhang Zhan. The convening, holding and voting procedures of the meeting complied with the provisions of the Company Law and other relevant laws, regulations and the Articles of Association.
2. Review status of board of directors meeting
After deliberation item by item and written voting, the meeting reviewed and approved the following proposals:
- Reviewed and approved the "Proposal on the General Manager's Work Report for 2025";
The directors attending the meeting carefully listened to the "2025 General Manager Work Report" made by the company's general manager, and believed that the report objectively and truly reflected the company's implementation of the resolutions of the board of directors and shareholders' meeting and the management of various production and operation activities in 2025.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
- Considered and approved the "Proposal on the Work Report of the Board of Directors in 2025";
In 2025, the company's board of directors will operate in a standardized manner in accordance with the requirements of the Company Law, Securities Law, and Articles of Association, strictly follow the authorization of the shareholders' meeting, and conscientiously implement various resolutions passed by the shareholders' meeting.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal still needs to be submitted to the company's 2025 annual shareholders' meeting for review.
The company's current independent directors, Ms. Wang Yanmei, Ms. Huang Juan, and Mr. Zhang Jianping, and the independent directors who have resigned during the reporting period, Mr. Wang Xinmin and Mr. Yang Xinfa, respectively submitted the "2025 Independent Directors' Work Report" and "Independent Directors' Independence Self-examination Report" to the board of directors. Based on the self-examination report and investigation and verification, the board of directors evaluated the independence of the company's current independent directors in 2025 and believed that the company's independent directors complied with the "Measures for the Administration of Independent Directors of Listed Companies" and other regulations on the qualifications and independence of independent directors, and issued the "Special Opinions of the Board of Directors on the Assessment of the Independence of Independent Directors."
For details, please refer to the relevant announcement published on the Juchao Information Network (www.cninfo.com.cn) on the same day. 3. Considered and approved the "Proposal on the 2025 Annual Report and its Summary";
For details of the company's "2025 Annual Report" and its summary, please refer to the relevant announcements published on the designated information disclosure media and the cninfo website (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal has been reviewed and approved by the Audit Committee of the Company’s Board of Directors and still needs to be submitted to the Company’s 2025 Annual Shareholders’ Meeting for review.
- Reviewed and approved the "Proposal on the Profit Distribution Plan for 2025";
Based on the company's future development needs, the board of directors has comprehensively considered the level of shareholder returns and the company's actual operating conditions, and has formulated the company's profit distribution plan for 2025 as follows: Based on the company's total share capital of 226,800,000 shares as of December 31, 2025, a cash dividend of 2 yuan (tax included) will be distributed for every 10 shares, and the total cash dividend proposed to be distributed is 45,360,000.00. Yuan, no shares will be given out, and public reserves will not be converted into share capital. If the company's total share capital changes before the implementation of the distribution plan, the distribution ratio will be adjusted accordingly based on the principle that the total amount of distribution remains unchanged. For details, please refer to the "Announcement on the 2025 Profit Distribution Plan" published on the designated information disclosure media and the cninfo website (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal still needs to be submitted to the company's 2025 annual shareholders' meeting for review.
- Considered and approved the "Proposal on the Internal Control Evaluation Report for 2025";
The company has maintained effective internal control in all major aspects in accordance with the requirements of the corporate internal control standard system and other relevant regulations. The "2025 Internal Control Evaluation Report" truly and objectively reflects the construction and operation of the company's internal control system.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
For details, please refer to the relevant announcement published on the Juchao Information Network (www.cninfo.com.cn) on the same day. This proposal has been reviewed and approved by the Audit Committee of the Company's Board of Directors.
- Reviewed and approved the "Proposal on the Implementation of Daily Related Transactions in 2025 and Expected Daily Related Transactions in 2026";
In 2025, the related transactions between the company and relevant related parties are normal business transactions and are priced based on fair market prices and in accordance with the principles of fairness and reasonableness. For details, please refer to the "Announcement on the Implementation of Daily Related Transactions in 2025 and Expected Daily Related Transactions in 2026" published on the designated information disclosure media and the cninfo.com (www.cninfo.com.cn) on the same day.
Voting results: 6 votes in favor, 0 votes against, 0 abstentions. Related directors Mr. Zhang Zhan, Ms. Guo Caiping and Mr. Li Ligang abstained from voting.
This proposal has been reviewed and approved by the company’s special meeting of independent directors and the audit committee of the board of directors.
- The "Proposal on the 2025 Environmental, Social and Corporate Governance (ESG) Report" was reviewed and approved; the Board of Directors reviewed and approved the "2025 Environmental, Social and Corporate Governance (ESG) Report" prepared by the company. The report objectively and in detail reflects the company's performance in environmental protection, social responsibility and corporate governance (ESG) during the reporting period.
For details, please refer to the relevant announcement published on the Juchao Information Network (www.cninfo.com.cn) on the same day. Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
- The "Proposal on Developing the Remuneration Management System for Directors and Senior Management Personnel" was reviewed and approved; in order to further improve the remuneration management of the company's directors and senior management personnel, in accordance with the provisions of the "Code of Governance for Listed Companies" and other provisions, and based on the actual situation, the company formulated the "Remuneration Management System for Directors and Senior Management Personnel of Shenzhen Weiguang Biological Products Co., Ltd.". For details, please refer to the relevant announcement published on the cninfo.com (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
This proposal has been reviewed and approved by the Remuneration and Appraisal Committee of the Board of Directors.
- The "Proposal on Convening the 2025 Annual Shareholders' Meeting" was reviewed and approved.
After deliberation, the board of directors agreed to convene the company's 2025 annual shareholders' meeting on May 18, 2026. For details, please refer to the "Notice of the 2025 Annual Shareholders Meeting" published on the designated information disclosure media and the cninfo website (www.cninfo.com.cn) on the same day.
Voting results: 9 votes in favor, 0 votes against, and 0 abstentions.
3. Documents for reference
Resolution of the ninth meeting of the fourth board of directors;
Resolutions of relevant special committee meetings of the board of directors.
Announcement is hereby made.
Board of Directors of Shenzhen Weiguang Biological Products Co., Ltd.
April 27, 2026